NCT01325363

Brief Summary

The aim of this research is to investigate the neurolinguistic mechanisms underlying thought disorders among schizophrenic patients. In particular, it will investigate the neurolinguistic basis for loose association - a phenomena which this population is characterized by. Several researchers have previously suggested that loose associations among schizophrenic patients relate to a lack of inhibition in the automatic spread of activation mechanisms within semantic networks (e.g., Soriano, Jimenez, Roman, \& Bajo, 2008). This research focuses on the relationship between I. the left-right hemisphere dynamic and II. semantic processing, among schizophrenic patients. The research follows Jung-Beeman's (2005) model which relates semantic associations, activation and inhibition processes to the functioning of the two cerebral hemispheres. Previous research suggests that, when compared to the neurotypical population, people with schizophrenia show a less defined - or even reversed - hemispheric lateralization pattern for semantic processing. This is linked to an impairment in language function in the left hemisphere, and to a language functions shift from left to right hemisphere (e.g., Crow, 1997). The investigators assume that this unique lateralization pattern may cause a change in balance in the semantic activation and inhibition system among schizophrenic patients. As stated, one of the linguistic models that predicts how reduced left hemisphere dominancy will influence linguistic functioning is Jung-Beeman's (2005) bilateral model for language understanding. According to this model, the left hemisphere specializes in precise and fine semantic processing, while the right hemisphere specializes in coarse and abstract semantic processing. Building upon this distinction, our assumption is that schizophrenic patients experience a difficulty in fine semantic processing which is caused by functional impairment in the left hemisphere. It is our further assumption that coarse semantic processing - located in the right hemisphere - is relatively unimpaired. This change in the balance between the two processes may have direct implications on the associative semantic network among schizophrenic patients. In order to test this hypothesis, the current research will make use of a specific language expression type which involves fine and coarse semantic processing, and for which there is evidence for crucial right hemisphere involvement: novel metaphor processing. 10-20 adult schizophrenic patients will be presented with four different types of two word expressions: literal; conventional metaphor; novel metaphor and unrelated. The patients will have to decide as quickly and accurately as possible if the expression is meaningful or meaningless while their brain activity is recorded by a Magnetoencephalographic (MEG) device (which combines a high temporal resolution with the ability to localize the activity). Therefore, our main hypothesis is that schizophrenic patients will show a bilateral brain activity pattern when conducting semantic decisions, and that this pattern will be related to improved reaction times and accuracy when presented with novel metaphors than when presented with other types of expressions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable schizophrenia

Timeline
Completed

Started Apr 2011

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 29, 2011

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

March 8, 2012

Status Verified

March 1, 2012

Enrollment Period

8 months

First QC Date

March 27, 2011

Last Update Submit

March 7, 2012

Conditions

Keywords

SchizophreniaNovel metaphor

Outcome Measures

Primary Outcomes (1)

  • Amplitude power and source location of the magnetic brain activity

    Magnetic brain activity which was recorded during the experimental task, will be cleaned from artifacts, averaged over participants and then the amplitude power of each condition in each group will be calculated for different time windows. In a subsequent analysis, the source location of the activity will be calculated using Beamforming techniques.

    one hour

Study Arms (2)

Schizophrenia

EXPERIMENTAL

Schizophrenic patients

Device: Magnetoencephalograph (MEG)

Control

EXPERIMENTAL

Neurotypical subjects

Device: Magnetoencephalograph (MEG)

Interventions

Brain imaging device that records the magnetic fields in the brain.

Also known as: MAGNES STIMULUS, 4-D NEUROIMAGING, 9727 Pacific heights blvd., San Diego, CA 92121, USA.
ControlSchizophrenia

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Schizophrenic patients according to Diagnostic and Statistical Manual of Mental Disorders (DSM IV) or International Classification of Diseases (ICD-10)
  • Hebrew native speakers

You may not qualify if:

  • Language disabilities
  • Left handed
  • Reading disabilities
  • Brain damage
  • Impaired intelligence
  • Metal implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

shalvata MHC

Hod HaSharon, Israel

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2011

First Posted

March 29, 2011

Study Start

April 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

March 8, 2012

Record last verified: 2012-03

Locations